Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Immunology|January 1, 2022
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary ImmunodeficiencyManuel Santamaria, Olaf Neth, Jo A Douglass, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 30, 2010
HAE international home therapy consensus documentHilary J Longhurst, Henriette Farkas, Timothy Craig, et al.
Frontiers in Immunology|October 10, 2022
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experienceAdrian M Shields, Susan Tadros, Adam Al-Hakim, et al.
The Journal of Infection|May 21, 2025
Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR studyJudith Breuer, Myriam Drysdale, Jill Walker, et al.
Journal of Clinical Immunology|April 14, 2022
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
Frontiers in Immunology|June 20, 2022
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
The Lancet. Infectious Diseases|June 22, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trialIvan T Lee, Catherine A Cosgrove, Patrick Moore, et al.
The Journal of Allergy and Clinical Immunology|January 1, 2023
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung diseaseBas Smits, Sigune Goldacker, Suranjith Seneviratne, et al.
Journal of Clinical Immunology|September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-TelangiectasiaStefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2018
Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic diseaseBatsukh Dorjbal, Jeffrey R Stinson, Chi A Ma, et al.
Pageof 3